• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双醋瑞因对破骨细胞性骨破坏的抑制作用及其可能的作用机制

[Inhibitory effect of diacerein on osteoclastic bone destruction and its possible mechanism of action].

作者信息

Wang Lin, Mao Yu-Jia, Wang Wen-Jie

机构信息

Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union, Medical College, Beijing 100050, China.

出版信息

Yao Xue Xue Bao. 2006 Jun;41(6):555-60.

PMID:16927832
Abstract

AIM

To study the inhibitory action of diacerein on the formation of osteoclasts (OCLs) and their activity in bone resorption as well as the relationship between this action and the expression of osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in MC3T3-E1 cells.

METHODS

A coculture system constituted with MC3T3-E1 cells and bone marrow cells for osteoclasts formation was established in vitro. TRAP-positive and multinucleated cells with three or more nuclei in each cell were counted as osteoclasts and the number of pits formed on the dentine slices was determined to judge the activity of osteoclasts. Western blotting, RT-PCR and flow cytometer were used to detect the expression of OPG and RANKL in MC3T3-E1 cells.

RESULTS

Diacerein significantly inhibited the formation and function of the cultured osteoclasts stimulated by IL-1beta. sRANKL could reverse the effect of diacerein. Diacerein inhibited protein and mRNA expression of RANKL but enhanced those of OPG in MC3T3-E1 cells.

CONCLUSION

Diacerein may inhibit osteoclastic bone destruction through the inhibition of RANKL expression and the increase of OPG expression in MC3T3-E1 cells.

摘要

目的

研究双醋瑞因对破骨细胞(OCLs)形成及其骨吸收活性的抑制作用,以及该作用与MC3T3-E1细胞中骨保护素(OPG)和核因子κB受体活化因子配体(RANKL)表达之间的关系。

方法

体外建立由MC3T3-E1细胞和骨髓细胞组成的用于破骨细胞形成的共培养体系。将每个细胞中含有三个或更多核的抗酒石酸酸性磷酸酶(TRAP)阳性多核细胞计为破骨细胞,并测定牙本质切片上形成的凹坑数量以判断破骨细胞的活性。采用蛋白质免疫印迹法、逆转录-聚合酶链反应(RT-PCR)和流式细胞仪检测MC3T3-E1细胞中OPG和RANKL的表达。

结果

双醋瑞因显著抑制白细胞介素-1β(IL-1β)刺激的培养破骨细胞的形成和功能。可溶性RANKL(sRANKL)可逆转双醋瑞因的作用。双醋瑞因抑制MC3T3-E1细胞中RANKL的蛋白质和mRNA表达,但增强OPG的表达。

结论

双醋瑞因可能通过抑制MC3T3-E1细胞中RANKL的表达和增加OPG的表达来抑制破骨细胞性骨破坏。

相似文献

1
[Inhibitory effect of diacerein on osteoclastic bone destruction and its possible mechanism of action].双醋瑞因对破骨细胞性骨破坏的抑制作用及其可能的作用机制
Yao Xue Xue Bao. 2006 Jun;41(6):555-60.
2
Effects and mechanism of aromatic aminoketone SY0916 on osteoclastic bone destruction.芳香族氨基酮 SY0916 对破骨细胞性骨破坏的作用及其机制。
Acta Pharmacol Sin. 2010 Apr;31(4):470-5. doi: 10.1038/aps.2009.202. Epub 2010 Mar 8.
3
Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.肝素通过抑制骨保护素的活性来增强破骨细胞的骨吸收作用。
Bone. 2007 Aug;41(2):165-74. doi: 10.1016/j.bone.2007.04.190. Epub 2007 May 5.
4
Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.细胞内钙和蛋白激酶C介导成骨细胞中核因子-κB受体激活剂配体和骨保护素的表达。
Endocrinology. 2000 Dec;141(12):4711-9. doi: 10.1210/endo.141.12.7852.
5
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.成骨细胞产生的骨保护素是破骨细胞发育和功能的重要调节因子。
Endocrinology. 2000 Sep;141(9):3478-84. doi: 10.1210/endo.141.9.7634.
6
The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.成骨细胞与破骨细胞间的串扰在锶治疗中的反应:骨保护素的参与。
Bone. 2011 Dec;49(6):1290-8. doi: 10.1016/j.bone.2011.08.031. Epub 2011 Sep 9.
7
Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.成骨细胞/基质细胞通过表达破骨细胞分化因子/核因子κB受体活化因子配体(RANKL)而非巨噬细胞集落刺激因子来刺激破骨细胞活化:核因子κB受体活化因子配体。
Bone. 1999 Nov;25(5):517-23. doi: 10.1016/s8756-3282(99)00210-0.
8
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.衰老会增加基质/成骨细胞诱导的破骨细胞生成,并改变小鼠体内破骨细胞前体细胞库。
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
9
Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.骨保护素及核因子-κB受体激活因子配体(RANKL)在HCC70乳腺癌细胞中的表达以及促性腺激素释放激素处理对RANKL表达的影响
Gynecol Endocrinol. 2008 Jun;24(6):331-8. doi: 10.1080/09513590802095845.
10
Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.小檗碱通过调节成骨细胞中 RANKL 和 OPG 基因的表达,抑制破骨细胞前体中 RANKL 诱导的 NF-κB 磷酸化,从而抑制其功能。
J Nat Med. 2012 Jan;66(1):8-16. doi: 10.1007/s11418-011-0537-7. Epub 2011 Jun 9.

引用本文的文献

1
Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.关于抗关节炎药物在抑制大鼠骨关节炎进展过程中软骨退变和疼痛方面疗效的随机对照研究。
Arthritis Res Ther. 2016 Jan 21;18:24. doi: 10.1186/s13075-016-0921-5.
2
Inhibitory effects of morinda officinalis extract on bone loss in ovariectomized rats.巴戟天提取物对去卵巢大鼠骨质流失的抑制作用。
Molecules. 2009 Jun 8;14(6):2049-61. doi: 10.3390/molecules14062049.
3
Antiosteoporotic activity of anthraquinones from Morinda officinalis on osteoblasts and osteoclasts.
巴戟天蒽醌类化合物对成骨细胞和破骨细胞的抗骨质疏松活性
Molecules. 2009 Jan 23;14(1):573-83. doi: 10.3390/molecules14010573.